Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

19.87
Delayed Data
As of Aug 27
 +0.34 / +1.74%
Today’s Change
18.75
Today|||52-Week Range
33.60
-20.87%
Year-to-Date
No recent news for Sagent Pharmaceuticals Inc.

Today’s Trading

Previous close19.53
Today’s open19.69
Day’s range19.45 - 20.10
Volume225,106
Average volume (3 months)377,320
Market cap$638.4M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+23.23%
Earnings growth (this year)-104.57%
Earnings growth (next 5 years)+22.83%
Revenue growth (last year)+18.07%
P/E ratio21.8
Price/Sales2.85
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.07-2.57%
OMEROmeros Corp-0.49-3.02%
NWBONorthwest Biotherape...+0.43+5.46%
AMPHAmphastar Pharmaceut...+0.28+2.07%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$289.0M
Annual profit (last year)$39.9M
Net profit margin13.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allan Oberman
President, Secretary &
Chief Legal Officer
Michael Logerfo
Corporate headquarters
Schaumburg, Illinois

Forecasts

Partner Offers